Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 158

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 158
---
; (ii) the issuance of shares leading to a change of control; (iii) adoption/amendment 
 of equity compensation arrangements (although under the provisions of the Companies Law there is no requirement for shareholder approval        
 for the adoption/amendment of the equity compensation plan); and (iv) issuances of 20% or more of the shares or voting rights                   
 (including securities convertible into, or exercisable for, equity) of a listed company via a private placement (and/or via sales               
 by directors/officers/5% shareholders) if such equity is issued (or sold) at below the greater of the book or market value of shares.           
 By contrast, under the Companies Law, shareholder approval is required for, among other things: (i) arrangements with directors                 
 and with chief executive officer concerning the terms of their service or indemnification, exemption and insurance for their service            
 (or for any other position that they may hold at a company), for which approvals of the compensation committee, board of directors              
 and shareholders are all required, (ii) extraordinary transactions with controlling shareholders of publicly held companies,                    
 which require the special approval, (iii) terms of employment or other engagement of the controlling shareholder of us or such                  
 controlling shareholder’s relative, which require special approval and (iv) issuances of 20% or more of the shares or voting                    
 rights (including securities convertible into, or exercisable for, equity) of a listed company via a private placement (and/or via              
 sales by directors/officers/5% shareholders) if such equity is issued (or sold) at below the greater of the book or market value                
 of shares. In addition, under the Companies Law, a merger requires approval of the shareholders of each of the merging companies.               |
| ● | Approval of Related                                                                                                                             
 Party Transactions. All related party transactions are approved in accordance with the requirements and procedures for approval                 
 of interested party acts and transaction as set forth in the Companies Law, which requires the approval of the audit committee, or              
 the compensation committee, as the case may be, the board of directors and shareholders, as may be applicable, for specified transactions,      
 rather than approval by the audit committee or other independent body of our board of directors as required under NYSE American Section         
 713. See “Management—Board Practices—Approval of Related Party Transactions under Israeli Law” for additional                                   
 information.                                                                                                                                    |

<div align='center'>95</div>

| ● | Annual Shareholders                                                                                                                        
 Meeting.